PetIQ (Nasdaq:PETQ) - Stock Price, News & Analysis

PETQ Stock Overview

Operates as a pet medication and wellness company in the United States and internationally.

PETQ fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	3/6
Past Performance	2/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings are forecast to grow 59.98% per year

Became profitable this year

Risk Analysis

Interest payments are not well covered by earnings

Significant insider selling over the past 3 months

Large one-off items impacting financial results

Volatile share price over the past 3 months

PetIQ, Inc. Competitors

Patterson Companies

NasdaqGS:PDCO

US$2.2b

Henry Schein

NasdaqGS:HSIC

US$9.0b

Cardinal Health

NYSE:CAH

US$26.7b

Pennant Group

NasdaqGS:PNTG

US$1.1b

Price History & Performance

Summary of all time highs, changes and price drops for PetIQ
Historical stock prices
Current Share Price	US$30.50
52 Week High	US$30.68
52 Week Low	US$15.09
Beta	1.71
11 Month Change	39.33%
3 Month Change	52.81%
1 Year Change	54.82%
33 Year Change	17.53%
5 Year Change	3.81%
Change since IPO	30.79%

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

Aug 14

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Aug 09

Recent updates

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 16

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Aug 10

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Jun 14

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

Feb 11

PetIQ gains 1.84 % on $30M stock repurchase program

Sep 06

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Aug 23

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

Jul 27

Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?

May 06

There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital

Apr 02

The Prognosis For PetIQ

Feb 12

PetIQ: Economies Of Scale Will Kick In Eventually

Jan 03

PetIQ, Trupanion: Pet Care Industry Small Players Still Not Cheap Enough

Sep 09

Why We Think PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation Is Not Excessive At All

Jun 23

Shareholder Returns

	PETQ	US Healthcare	US Market
7D	-0.03%	1.1%	0.6%
1Y	54.8%	13.3%	22.9%

Return vs Industry: PETQ exceeded the US Healthcare industry which returned 13.9% over the past year.

Return vs Market: PETQ exceeded the US Market which returned 24.9% over the past year.

Price Volatility

Is PETQ's price volatile compared to industry and market?
PETQ volatility
PETQ Average Weekly Movement	13.7%
Healthcare Industry Average Movement	6.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.1%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PETQ's share price has been volatile over the past 3 months.

Volatility Over Time: PETQ's weekly volatility has increased from 8% to 14% over the past year.

About the Company

Founded	Employees	CEO	Website
2010	1,527	Cord Christensen	petiq.com

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.

PetIQ, Inc. Fundamentals Summary

How do PetIQ's earnings and revenue compare to its market cap?
PETQ fundamental statistics
Market cap	US$911.52m
Earnings (TTM)	US$13.19m
Revenue (TTM)	US$1.13b

68.6x

P/E Ratio

0.8x

P/S Ratio

Is PETQ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PETQ income statement (TTM)
Revenue	US$1.13b
Cost of Revenue	US$854.90m
Gross Profit	US$279.43m
Other Expenses	US$266.23m
Earnings	US$13.19m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.44
Gross Margin	24.63%
Net Profit Margin	1.16%
Debt/Equity Ratio	170.0%

How did PETQ perform over the long term?

See historical performance and comparison

PETQ Stock Overview

Rewards

Risk Analysis

PetIQ, Inc. Competitors

NasdaqGS:PDCO

US$2.2b

NasdaqGS:HSIC

US$9.0b

NYSE:CAH

US$26.7b

NasdaqGS:PNTG

US$1.1b

Price History & Performance

Recent News & Updates

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023)

New minor risk - Share price stability

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

Price target increased by 8.3% to US$30.33

Recent updates

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023)

New minor risk - Share price stability

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

Price target increased by 8.3% to US$30.33

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

President & COO exercised options and sold US$483k worth of stock

PetIQ, Inc. to Report Q2, 2024 Results on Aug 07, 2024

PetIQ: Product Margin Gains Offset By Higher Marketing Spend

Insider exercised options and sold US$89k worth of stock

Independent Director recently sold US$269k worth of stock

PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023)

PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024

PetIQ, Inc., Annual General Meeting, Jun 07, 2024

White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative

PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly

PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs

Chairman of the Board & CEO exercised options and sold US$362k worth of stock

Full year 2023 earnings released: EPS: US$0.073 (vs US$1.65 loss in FY 2022)

Petiq, Inc. Provides Sales Guidance for the First Quarter and Full Year of 2024

Chairman of the Board & CEO exercised options and sold US$154k worth of stock

PetIQ, Inc. to Report Q4, 2023 Results on Feb 28, 2024

PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate

Chief Financial Officer exercised options and sold US$97k worth of stock

PetIQ, Inc.'s New Sentry™? Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: US$0.015 (vs US$1.68 loss in 3Q 2022)

Petiq, Inc. Provides Earnings Guidance for the Full Year of 2023

PetIQ, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investors Will Want PetIQ's (NASDAQ:PETQ) Growth In ROCE To Persist

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

PetIQ, Inc. Revises Earnings Guidance for the Full Year 2023

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Price target increased by 13% to US$27.50

Petiq, Inc. Announces Termination of R. Michael Herrman, as Executive Vice President and Corporate Secretary

PetIQ, Inc. to Report Q2, 2023 Results on Aug 08, 2023

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Petiq, Inc. Provides Earnings Guidance for the Second Quarter of 2023 and Reiterates Earnings Guidance for the Full Year 2023

First quarter 2023 earnings released: EPS: US$0.33 (vs US$0.11 in 1Q 2022)

Chairman of the Board & CEO exercised options and sold US$68k worth of stock

Full year 2022 earnings released: US$1.65 loss per share (vs US$0.56 loss in FY 2021)

Price target decreased by 10% to US$21.75

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

PetIQ, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Third quarter 2022 earnings released: US$1.68 loss per share (vs US$0.27 loss in 3Q 2021)

Price target decreased to US$24.25

PetIQ, Inc. to Report Q3, 2022 Results on Nov 09, 2022

President & COO recently bought US$97k worth of stock

PetIQ, Inc. (NasdaqGS:PETQ) announces an Equity Buyback for $30 million worth of its shares.

PetIQ gains 1.84 % on $30M stock repurchase program

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.14 in 2Q 2021)

PetIQ, Inc. Provides Sales Guidance for the Third Quarter and Full Year 2022

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

PetIQ, Inc. to Report Q2, 2022 Results on Aug 09, 2022

High number of new directors

PetIQ, Inc. Appoints John Pearson as Senior Vice President, Head of Services Division